Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 25.54 billion as of March 9, 2026. Its market cap has increased by 7.33% in one year.

Market Cap

25.54B

Enterprise Value

22.52B

Revenue

6.50B

Ranking

n/a

PE Ratio

1.05

Stock Price

11.74

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 25.54B, an increase of 1,109.21%. That is a compound annual growth rate of 27.71%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	24.99B	-7.97%
Dec 31, 2025	27.15B	28.72%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
InnoCare Pharma	23.79B
PegBio	23.50B
Duality Biotherapeutics	28.45B
Shanghai Junshi Biosciences	32.13B
Biocytogen Pharmaceuticals (Beijing)	35.60B
Zai Lab	17.13B
TransThera Sciences (Nanjing)	36.71B
Ascentage Pharma Group International	16.66B

Market Cap Rankings